Innovent Biologics, Inc. (IVBXF)
10.35
-0.45
(-4.17%)
USD |
OTCM |
May 15, 16:00
Innovent Biologics Market Cap : 17.95B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sinovac Biotech Ltd. | 388.59M |
| CASI Pharmaceuticals, Inc. | 3.082M |
| Zai Lab Ltd. | 2.308B |
| Ascletis Pharma, Inc. | 2.261B |
| CanSino Biologics, Inc. | 953.59M |
Market Cap Related Metrics
| PE Ratio | 156.34 |
| PS Ratio | 9.775 |
| Price to Free Cash Flow | 13.26 |
| Price | 10.35 |
| Earnings Yield | 0.64% |
| Operating PE Ratio | 63.27 |
| Normalized PE Ratio | 156.58 |